Loading insider details...
Beta
Latest Form 4 (Aug 13, 2026): Grant/Award of 30,350 DMRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Damora Therapeutics, Inc. (DMRA) | Grant/Award | 30,350 | n/a |
| May 26, 2026 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 17,084 | n/a |
| Dec 9, 2025 | Akero Therapeutics, Inc. (AKRO) | Disposition to Issuer | 277,075 | n/a |
| Nov 21, 2025 | Akero Therapeutics, Inc. (AKRO) | Gift | 74,538 | n/a |
| Nov 14, 2025 | Akero Therapeutics, Inc. (AKRO) | Gift | 14,739 | n/a |
| Oct 15, 2025 | Akero Therapeutics, Inc. (AKRO) | Exercise/Conversion | 30,000 | $596.1K |
| Oct 9, 2025 | Akero Therapeutics, Inc. (AKRO) | Exercise/Conversion | 52,212 | $32.1K |
| Sep 13, 2025 | Akero Therapeutics, Inc. (AKRO) | Exercise/Conversion | 13,022 | $82.9K |
| Aug 13, 2025 | Akero Therapeutics, Inc. (AKRO) | Sale | 10,795 | $518.9K |
| Jul 11, 2025 | Akero Therapeutics, Inc. (AKRO) | Sale | 14,686 | $742.7K |